The BCS, BDDCS, and Regulatory Guidances

被引：64

作者：

Chen, Mei-Ling ^{[1
]}

Amidon, Gordon L. ^{[2
]}

Benet, Leslie Z. ^{[3
]}

Lennernas, Hans ^{[4
]}

Yu, Lawrence X. ^{[5
]}

机构：

[1] US FDA, Off Pharmaceut Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA

[2] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA

[3] Univ Calif San Francisco, Sch Pharm & Med, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA

[4] Uppsala Univ, Dept Pharm, Uppsala, Sweden

[5] US FDA, Ctr Drug Evaluat & Res, Off Gener Drugs, Off Pharmaceut Sci, Rockville, MD 20857 USA

来源：

PHARMACEUTICAL RESEARCH | 2011年 / 28卷 / 07期

关键词：

BCS; BDDCS; biopharmaceutics classification system; biopharmaceutics drug disposition classification system; drug metabolism; drug permeability; BIOPHARMACEUTICS CLASSIFICATION-SYSTEM; DRUG DISPOSITION CLASSIFICATION; PERMEABILITY; ABSORPTION;

D O I：

10.1007/s11095-011-0438-1

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：1774 / 1778

页数：5

共 19 条

[1] Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996)
Artursson, P
Palm, K
Luthman, K
[J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) : 27 - 43
[2] The use of BDDCS in classifying the permeability of marketed drugs
Benet, Leslie Z.
Amidon, Gordon L.
Barends, Dirk M.
Lennernas, Hans
Polli, James E.
Shah, Vinod P.
Stavchansky, Salomon A.
Yu, Lawrence X.
[J]. PHARMACEUTICAL RESEARCH, 2008, 25 (03) : 483 - 488
[3] The biopharmaceutics classification system (BCS): Class III drugs - better candidates for BA/BE waiver?
Blume, HH
Schug, BS
[J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 9 (02) : 117 - 121
[4] The Use of Drug Metabolism for Prediction of Intestinal Permeability
Chen, Mei-Ling
Yu, Lawrence
[J]. MOLECULAR PHARMACEUTICS, 2009, 6 (01) : 74 - 81
[5] *COMM MED PROD HUM, 2010, GUID INV BIOEQ LENC
[6] High-Permeability Criterion for BCS Classification: Segmental/pH Dependent Permeability Considerations
Dahan, Arik
Miller, Jonathan M.
Hilfinger, John M.
Yamashita, Shinji
Yu, Lawrence X.
Lennernas, Hans
Amidon, Gordon L.
[J]. MOLECULAR PHARMACEUTICS, 2010, 7 (05) : 1827 - 1834
[7] GL A, 1995, Pharm Res, V12, P413
[8] Computational models to assign biopharmaceutics drug disposition classification from molecular structure
Khandelwal, Akash
Bahadduri, Praveen M.
Chang, Cheng
Polli, James E.
Swaan, Peter W.
Ekins, Sean
[J]. PHARMACEUTICAL RESEARCH, 2007, 24 (12) : 2249 - 2262
[9] Intestinal permeability and its relevance for absorption and elimination
Lennernas, H.
[J]. XENOBIOTICA, 2007, 37 (10-11) : 1015 - 1051
[10] The use of biopharmaceutic classification of drugs in drug discovery and development:: current status and future extension
Lennernäs, H
Abrahamsson, B
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (03) : 273 - 285

← 1 2 →